Goldman Sachs’s LifePoint Health, Inc. LPNT Stock Holding History

Goldman Sachs’s Portfolio LPNT Stock Details LPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-200	Closed	-$13K	–	7146
2017 Q2	$13K	Buy	+200	New	+$12.6K	﹤0.01%	6632
2016 Q4	–	Sell	-2,200	Closed	-$130K	–	7339
2016 Q3	$130K	Sell	2,200 -7,400	-77%	-$444K	﹤0.01%	6094
2016 Q2	$628K	Buy	9,600 +3,300	+52%	+$224K	﹤0.01%	4636
2016 Q1	$436K	Buy	6,300 +6,200	+6,200%	+$414K	﹤0.01%	4880
2015 Q4	$7K	Sell	100 -2,400	-96%	-$171K	﹤0.01%	7025
2015 Q3	$177K	Hold	2,500	–	–	﹤0.01%	6101
2015 Q2	$217K	Buy	2,500 +2,200	+733%	+$166K	﹤0.01%	6072
2015 Q1	$22K	Sell	300 -3,700	-93%	-$263K	﹤0.01%	6893
2014 Q4	$288K	Buy	4,000 +1,000	+33%	+$69.3K	﹤0.01%	5831
2014 Q3	$208K	Buy	+3,000	New	+$211K	﹤0.01%	6132

Other funds holding LPNT

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Goldman Sachs's LPNT Position: Q4 2018 in Review

Goldman Sachs sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 323,313 shares — an estimated $20.8M sold.

Goldman Sachs first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $26.7M in Q1 2017. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

Goldman Sachs reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
Goldman Sachs sold 323,313 LifePoint Health, Inc. shares in Q4 2018, an estimated $20.8M.
Goldman Sachs first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
Goldman Sachs's LifePoint Health, Inc. position peaked at $26.7M in Q1 2017.
3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.